Transcenta Holding (HKSE:06628) Long-Term Debt : HK$23.90 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Transcenta Holding Long-Term Debt?

Transcenta Holding's Long-Term Debt for the quarter that ended in Jun. 2024 was HK$23.90 Mil.

Transcenta Holding's quarterly Long-Term Debt declined from Jun. 2023 (HK$65.63 Mil) to Dec. 2023 (HK$11.49 Mil) but then increased from Dec. 2023 (HK$11.49 Mil) to Jun. 2024 (HK$23.90 Mil).

Transcenta Holding's annual Long-Term Debt declined from Dec. 2021 (HK$94.76 Mil) to Dec. 2022 (HK$17.87 Mil) and declined from Dec. 2022 (HK$17.87 Mil) to Dec. 2023 (HK$11.49 Mil).

Transcenta Holding Long-Term Debt Historical Data

The historical data trend for Transcenta Holding's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transcenta Holding Long-Term Debt Chart

Transcenta Holding Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

189.06

173.00

94.76

17.87

11.49

Transcenta Holding Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Long-Term Debt	Get a 7-Day Free Trial					83.10	17.87	65.63	11.49	23.90

Transcenta Holding (HKSE:06628) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Transcenta Holding Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Transcenta Holding's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Transcenta Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transcenta Holding Ltd (HKSE:06628) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

B6-501, 218 Xinghu Street, Biobay, Suzhou, CHN, 215123

Website

https://www.transcenta.com

Transcenta Holding Ltd is a clinical-stage biopharmaceutical company with fully integrated capacities in discovery, research, development, and manufacturing. It is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Geographically the company operates in China (the PRC) and the USA.

Executives

Qian Xueming	2101 Beneficial owner
Shi Xiaohong	2501 Other
Lav Corporate Gp, Ltd.	2201 Interest of corporation controlled by you
Lav Gp Iii, L.p.	2201 Interest of corporation controlled by you
Lav Biosciences Fund Iii, L.p.	2101 Beneficial owner
Shi Yi	2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited	2102 Investment manager
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited
Tls Beta Pte. Ltd.
Hsbc Trust Company (delaware), N.a.	2301 Trustee
Success Link International L.p.	2101 Beneficial owner
Temasek Holdings (private) Limited
Lav Vitality Limited	2101 Beneficial owner
Zhong Guo Guo You Qi Ye Jie Gou Tiao Zheng Ji Jin Gu Fen You Xian Gong Si	2501 Other

Transcenta Holding Headlines

No Headlines